LVAD bloodstream infections: Therapeutic rationale for transplantation after LVAD infection

Journal of Heart and Lung Transplantation

Volumn 22, Issue 8, 2003, Pages 914-921

  Poston, Robert S ^a   Husain, Shahid ^b   Sorce, Damian ^b   Stanford, Ellieen ^b   Kusne, Shimon ^b   Wagener, Margaret ^b   Griffith, Bartley P ^a   Kormos, Robert L ^b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BLEEDING; BLOOD FLOW; BLOOD TRANSFUSION; DEVICE INFECTION; ERYTHROCYTE CONCENTRATE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; HYPOALBUMINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTUBATION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MORTALITY; NUTRITION; PLASMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REINFECTION; RISK FACTOR; THROMBOCYTE;

EID: 0043167801     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00645-9     Document Type: Article

References (29)

1. Rose E.A. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 345:(20):2001;1435-1443.
2. United Network for Organ Sharing. Allocation of Thoracic Organs Policy 3.7 (available at URL:http//www.unos.org). Richmond VA: United Network of Organ Sharing.
3. Fischer S.A., Trenholme G.M., Costanzo M.R., et al. Infectious complications in left ventricular assist device recipients. Clin Infect Dis. 24:(1):1997;18-23.
4. McKellar S.H., Allred B.D., Marks J.D., et al. Treatment of infected left ventricular assist device using antibiotic-impregnated beads. Ann Thorac Surg. 67:1999;554-555.
5. Turowski G.A., Orgill D.P., Cooper G.S. Salvage of externally exposed ventricular assist devices. Plast Reconstr Surgery. 102:(7):1998;2425-2430.
6. de Jonge K.C., Laube H.R., Dohmen P.M., et al. Diagnosis and management of left ventricular assist device valve-endocarditis LVAD valve replacement . Ann Thorac Surg. 70:2000;1404-1405.
7. McCarthy P.M., Schmitt S.K., Vargo R.L., et al. Implantable LVAD Infections implications for permanent use of the device . Ann Thorac Surg. 61:1996;359-365.
8. CDC definition for nosocomial infections 1988. Am J Infect Control 1988;16:128-40.
9. Herrmann M., Weyland M., Creshake B., et al. Left ventricular device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation. 95:1997;814-817.
10. Vilchez R.A., McEllistrem M.C., Harrison L.H., et al. Relapsing bacteremia in patients with ventricular assist device an emergent complication of extended circulatory support . Ann Thorac Surg. 72:2001;96-101.
11. Gordon S.M., Schmitt S.K., Jacobs M., et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg. 72:2001;725-730.
12. Myers T.J., Khan T., Frazier O.H. Infectious complications associated with ventricular assist systems. ASAIO J. 46:(6):2000;S28-36.
13. Phillips W.S., Burton N.A., Macmanus Q., et al. Surgical complications in bridging to transplantation the Thermo Cardiosystems LVAD . Ann Thorac Surg. 53:1992;482-485.
14. Holman W.L., Skinner J.L., Waites K.B., et al. Infection during circulatory support with ventricular assist devices. Ann Thorac Surg. 68:1999;711-716.
15. Smart F.W., Naftel D.C., Costanzo M.R., et al. Risk factors for early, cumulative, and fatal infections after heart transplantation a multiinstitutional study . J Heart Lung Transplant. 15:(4):1996;329-341.
16. Masters R.G., Hendry P.J., Davies R.A., et al. Cardiac transplantation after mechanical circulatory support a Canadian perspective . Ann Thorac Surg. 61:1996;1734-1739.
17. Bank A.J., Mir S.H., Nguyen D.Q., et al. Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. Ann Thorac Surg. 69:2000;1369-1374.
18. Nurozler F., Argenziano M., Oz M.C., et al. Fungal left ventricular assist device endocarditis. Ann Thorac Surg. 71:2001;614-618.
19. Argenziano M., Catanese K.A., Moazami N., et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant. 16:(8):1997;822-831.
20. Sinha P., Chen J.M., Flannery M., et al. Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation. 102:(suppl3):2000;III194-199.
21. Murphy P.J., Connery C., Hicks G.L. Jr, et al. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. J Thorac Cardiovasc Surg. 104:1992;1092-1099.
22. von Eiff C., Becker K., Machka K., et al. Nasal carriage as a source of S aureus bacteremia . N Engl J Med. 344:(1):2000;11.
23. Morrone T.M., Buck L.A., Catanese K.A., et al. Early progressive mobilization of patients with left ventricular assist devices is safe and optimizes recovery before heart transplantation. J Heart Lung Transplant. 15:(4):1996;423-429.
24. Allen C., DelMar C. Bed rest a potentially harmful treatment needing more careful evaluation . Lancet. 354:1999;1229-1233.
25. Catanese K.A., Goldstein D.J., Williams D.L., et al. Outpatient left ventricular assist device support a destination rather than a bridge . Ann Thorac Surg. 62:1996;646-652.
26. Perioperative total parenteral nutrition in surgical patients. N Engl J Med. 325:(8):1991;525-532.
27. Tepaske R., Velthuis H., Oudemans-van Straaten H.M., et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery a randomised placebo-controlled trial . Lancet. 358:2001;696-701.
28. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 345:(19):2001;1359-1367.
29. Greif R., Akça O., Horn E.P., et al. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med. 342:2000;161-167.